Birch Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Birch Financial Group's BMY Position: Q2 2026 in Review
Birch Financial Group increased its Bristol-Myers Squibb (BMY) stake by 1.9% in Q2 2026, buying an estimated $4.13K and bringing the position to 3,805 shares worth $219K. The position accounts for 0.11% of the portfolio, ranked #128.
Birch Financial Group first reported a position in BMY in Q1 2025 and has held it in 3 quarters since. The position peaked at $226K in Q1 2026. 953 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Birch Financial Group held 3,805 shares of Bristol-Myers Squibb worth $219K as of Q2 2026.
- Birch Financial Group bought 72 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.13K.
- Bristol-Myers Squibb made up 0.11% of Birch Financial Group's portfolio in Q2 2026, its #128 holding.
- Birch Financial Group first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 3 quarters since.
- Birch Financial Group's Bristol-Myers Squibb position peaked at $226K in Q1 2026.
- 953 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Birch Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.